Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Integrative Biology
- Ownership
- Private
- Development stage
- Other
01
Overview
Integrative Biology was a biotechnology company focused on utilizing systems biology and computational approaches to drug discovery and development. The company aimed to integrate diverse biological data sets to identify novel therapeutic targets and biomarkers, particularly in the fields of oncology and infectious diseases. By leveraging advanced modeling and simulation techniques, Integrative Biology sought to streamline the drug development process and improve the success rates of clinical candidates. The company was eventually acquired, and its technologies and expertise were integrated into the operations of the acquiring entity.
- Therapeutic areas
- OncologyInfectious Diseases
- Modalities
- Small molecule
- Industry
- Biotech
Beyond the preview
Go deeper on Integrative Biology.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Integrative Biology.